Oppenheimer Starts Ligand Pharma (LGND) at Outperform
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $293.27 --0%
Rating Summary:
14 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 8
Rating Summary:
14 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 8
Join SI Premium – FREE
Oppenheimer initiates coverage on Ligand Pharma (NASDAQ: LGND) with a Outperform rating and a price target of $135.00.
For an analyst ratings summary and ratings history on Ligand Pharma click here. For more ratings news on Ligand Pharma click here.
Shares of Ligand Pharma closed at $101.35 yesterday.
You May Also Be Interested In
- JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'
- Citi Starts Sibyane Stillwater (SBSW) at Buy
- Benchmark Resumes MACOM Technology Solutions (MTSI) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
